Abstract
The correlation between infant leukemia and in utero exposure to topoisomerase II (topo-II) inhibitor has been clarified. We examined the in vitro effect of topo-II inhibitor (etoposide) on cleavage of theMLL gene in cord and peripheral blood mononuclear cells (MNCs). Southern blot analysis showed cleavage of theMLL gene in peripheral blood MNCs of infants when the MNCs were exposed to etoposide. MNCs were incubated with etoposide at various concentrations (1 to 50 µM), and a ligation-mediated polymerase chain reaction (LM-PCR) was used to detect double strand breaks (DSBs) of DNA in intron 8 of theMLL breakpoint cluster region. PCR products obtained with LM-PCR were subcloned and sequenced to identify the breakpoint in theMLL gene. The PCR products indicated DSBs of theMLL gene were obtained without any difference in the incidence between 3 different samples (cord and peripheral blood from infants and children). Sequencing analysis showed that the DSBs occurred on the telomeric side of intron 8 and near exon 9. There was no evidence that the cord blood was more susceptible toMLL DNA breakage by topo-II inhibitor than were other cells. Instability of the partner gene during the fetal period could be associated with the pathogenesis of infant leukemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Greaves M. Infant leukemia biology, aetiology and treatment.Leukemia. 1996;10:372–377.
Ishii E, Okamura J, Tsuchida M, et al. Infant leukemia in Japan: clinical and biological analysis of 48 cases.Med Pediatr Oncol. 1991;19:28–32.
Pui C, Crist WM. Biology and treatment of acute lymphoblastic leukemia.J Pediatr. 1994;124:491–503.
Winick NJ, McKenna RW, Shuster JJ, et al. Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.J Clin Oncol. 1993;11:209–217.
Sandoval C, Pui C, Bowman LC, et al. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.J Clin Oncol. 1993;11:1039–1045.
Domer PH, Head DR, Renganathan N, Raimondi SC, Yang E, Atlas M. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus- binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).Leukemia. 1995;9:1305–1312.
Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias.Nature. 1993;363:358–360.
Mahmoud HH, Ridge SA, Behm FG, et al. Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins.Med Pediatr Oncol. 1995;24:77–81.
Alexander FE, Patheal SL, Biondi A, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion.Cancer Res. 2001;61:2542–2546.
Felix CA. Secondary leukemias induced by topoisomerase-targeted drugs.Biochim Biophys Acta. 1998;1400:233–255.
Aplan PD, Chervinsky DS, Stanulla M, Burhans WC. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.Blood. 1996;87:2649–2658.
Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.Proc Natl Acad Sci U S A. 2000;97: 4790–4795.
Schlissel M, Constantinescu A, Morrow T, Baxter M, Peng A. Double-strand signal sequence breaks in V(D)J recombination are blunt, 5′-phosphorylated, RAG-dependent, and cell cycle regulated.Genes Dev. 1993;7:2520–2532.
Schlissel MS. Structure of nonhairpin coding-end DNA breaks in cells undergoing V(D)J recombination.Mol Cell Biol. 1998;18: 2029–2037.
Staley K, Blaschke AJ, Chun J. Apoptotic DNA fragmentation is detected by a semiquantitative ligation-mediated PCR of blunt DNA ends.Cell Death Differ. 1997;4:66–75.
Eguchi-Ishimae M, Eguchi M, Ishii E, et al. Breakage and fusion of the TEL (ETV6) gene in immature B-lymphocytes induced by apoptogenic signals.Blood. 2001;97:737–743.
Broeker PL, Super H, Thirman MJ, et al. Distribution of 11q23 breakpoints within theMLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.Blood. 1996;87:1912–1922.
Strissel PL, Strick R, Rowley JD, Zeleznik-Le NJ. An in vivo topo- isomerase II cleavage site and a DNase I hypersensitive site colo- calize near exon 9 in theMLL breakpoint cluster region.Blood. 1998;92:3793–3803.
Cimino G, Rapanotti MC, Biondi A, et al. Infant acute leukemias show the same biased distribution ofALL1 gene breaks as topo- isomerase II related secondary acute leukemia.Cancer Res. 1997; 57:2879–2883.
Stanulla M, Wang J, Chervinsky DS, Thandla S, Aplan PD. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stage of apoptosis.Mol Cell Biol. 1997;17: 4070–4079.
Spitzner JR, Muller MT. A consensus sequence for cleavage by vertebrate topoisomerase II.Nucleic Acids Res. 1988;16:5533–5556.
Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robinson LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia: a report from the Children’s Cancer Group.Cancer Causes Control. 1996;7:581–590.
Super HJ, McCabe NR, Thirman MJ, et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA topoisomerase II.Blood. 1993;82:3705–3711.
Lovett BD, Strumberg D, Blair IA, et al. Etoposide metabolites enhance DNA topoisomerase II cleavage near leukemia-associatedMLL translocation breakpoints.Biochemistry. 2001;40;1159–1170.
Ross JA. Dietary flavonoids and the MLL gene: a pathway to infant leukemia?Proc Natl Acad Sci U S A. 2000;97:4411–4413.
Marschalek R, Greil J, Lochner K, et al. Molecular analysis of the chromosomal breakpoint and fusion transcripts in the acute lym- phoblastic SEM cell line with chromosomal translocation t (4;11).Br J Haematol 1995;90:308–320.
Strout MP, Marcucci G, Bloomfield CD, Caligiuri MA. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia.Proc Natl Acad Sci U S A. 1998;95:2390–2395.
Gu Y, Alder H, Nakamura T, et al. Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia.Cancer Res. 1994;54:2327–2330.
Atlas M, Head D, Behm F, et al. Cloning and sequence analysis of four t (9;11) therapy-related leukemia breakpoints.Leukemia. 1998;12:1895–1902.
Yamamoto S, Zaitsu M, Ishii E, et al. High frequency of fusion transcripts of exon 11 and exon 4/5 in AF-4 gene is observed in cord blood, as well as leukemic cells from infant leukemia patients with t(4;11)(q21;q23).Leukemia. 1998;12:1398–1403.
DiMartino JF, Clearly ML. MLL rearrangements in hematological malignancies: lessons from clinical and biological studies.Br J Haematol. 1999;106:614–626.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ishii, E., Eguchi, M., Eguchi-Ishimae, M. et al. In Vitro Cleavage of theMLL Gene by Topoisomerase II Inhibitor (Etoposide) in Normal Cord and Peripheral Blood Mononuclear Cells. Int J Hematol 76, 74–79 (2002). https://doi.org/10.1007/BF02982722
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02982722